Skip to content

Clinical trials

Lymphangioleiomyomatosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphangioleiomyomatosis Country / region: France Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20121
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires1
University Hospital, Strasbourg, France1
University Hospital, Tours1
Vincent COTTIN1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphangioleiomyomatosis6
Angiomyolipoma2
Tuberous Sclerosis2
Astrocytoma1
Hereditary Sensory and Autonomic Neuropathies1
Hypertension, Pulmonary1
Perivascular Epithelioid Cell Neoplasms1
Seizures1

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.